Profile data is unavailable for this security.
About the company
Align Technology, Inc. designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment. The Clear Aligner segment consists of its Invisalign System, which includes Invisalign Full, Teen and Assist (Comprehensive Products), Express/Lite (Non-Comprehensive Products) and Vivera Retainers, along with its training and ancillary products for treating malocclusion (Non-Case). The Scanner segment consists of intra-oral scanning systems and other services available with the intra-oral scanners that provide digital alternatives to the traditional cast models. The Scanner segment includes its iTero scanner and OrthoCAD services.
- Revenue in USD (TTM)1.60bn
- Net income in USD318.86m
- Incorporated1997
- Employees8.72k
- LocationAlign Technology Inc2560 Orchard PkwySAN JOSE 95131-1033United StatesUSA
- Phone+1 (408) 738-1500
- Fax+1 (408) 470-1010
- Websitehttp://www.aligntech.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Inc. | 2.27bn | 439.59m | 15.61bn | 6.08k | 35.72 | 7.55 | 28.08 | 6.87 | 3.06 | 2.14 | 15.84 | 14.48 | 0.6535 | 3.46 | 4.99 | 373,890.10 | 12.64 | 13.27 | 14.27 | 15.80 | 58.22 | 60.21 | 19.34 | 19.64 | 2.85 | 35.06 | 0.2816 | 44.14 | 12.40 | 8.59 | -2.87 | 6.08 | 3.18 | -- |
| ABIOMED, Inc. | 593.75m | 133.57m | 19.08bn | 1.14k | 146.71 | 27.50 | 131.96 | 32.13 | 2.91 | 2.45 | 12.95 | 15.54 | 0.8883 | 2.32 | 9.57 | 519,465.40 | 19.98 | 17.28 | 22.59 | 19.66 | 83.40 | 83.34 | 22.50 | 19.35 | 5.24 | -- | 0.00 | 0.00 | 33.34 | 30.29 | 156.29 | 54.83 | 81.50 | -- |
| IDEXX Laboratories, Inc. | 2.04bn | 314.58m | 20.83bn | 7.60k | 68.06 | -- | 52.29 | 10.19 | 3.52 | 3.17 | 22.90 | -0.5664 | 1.34 | 5.14 | 8.34 | 269,038.60 | 20.69 | 15.34 | 45.73 | 33.36 | 55.87 | 55.25 | 15.39 | 13.13 | 0.7171 | 13.08 | 1.06 | 0.00 | 10.91 | 8.77 | 32.47 | 10.53 | 5.56 | -- |
| Zimmer Biomet Holdings Inc | 7.86bn | 416.70m | 23.12bn | 18.20k | 55.72 | 1.93 | 15.66 | 2.94 | 2.04 | 8.28 | 38.54 | 59.02 | 0.2904 | 1.08 | 5.21 | 432,109.90 | 1.54 | 2.75 | 1.74 | 3.02 | 71.86 | 71.34 | 5.31 | 8.08 | 1.07 | 4.82 | 0.4808 | 33.44 | 1.82 | 11.84 | 76.99 | -6.43 | 13.26 | 5.92 |
| Align Technology, Inc. | 1.60bn | 318.86m | 29.70bn | 8.72k | 95.05 | 26.34 | 81.58 | 18.56 | 3.90 | 3.16 | 19.57 | 14.07 | 0.987 | 11.02 | 5.09 | 183,591.00 | 19.91 | 15.31 | 27.37 | 20.04 | 75.55 | 75.69 | 20.17 | 17.93 | 2.19 | -- | 0.00 | 0.00 | 36.44 | 21.34 | 66.45 | 40.01 | 38.55 | -- |
| Edwards Lifesciences Corp | 3.45bn | 845.80m | 31.45bn | 12.20k | 37.73 | 9.69 | 33.97 | 9.12 | 3.95 | 2.60 | 16.08 | 15.40 | 0.65 | 1.78 | 7.52 | 282,508.20 | 15.95 | 16.77 | 19.43 | 19.54 | 74.08 | 74.12 | 24.54 | 23.70 | 1.63 | 126.62 | 0.2452 | 0.00 | 15.91 | 12.58 | 54.12 | 24.66 | 8.63 | -- |
| Baxter International Inc | 10.76bn | 1.43bn | 40.20bn | 47.00k | 28.84 | 4.41 | 18.41 | 3.74 | 2.59 | 1.50 | 19.52 | 16.96 | 0.6613 | 4.14 | 6.23 | 229,000.00 | 8.76 | 6.98 | 10.37 | 8.97 | 41.10 | 42.01 | 13.24 | 14.64 | 2.03 | 14.94 | 0.281 | 46.63 | 3.92 | -5.40 | -73.64 | -10.53 | -11.40 | -17.23 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2018 | 7.93m | 9.90% |
| BlackRock Fund Advisorsas of 31 Mar 2018 | 3.80m | 4.74% |
| Renaissance Technologies LLCas of 31 Mar 2018 | 2.96m | 3.69% |
| SSgA Funds Management, Inc.as of 31 Mar 2018 | 2.91m | 3.63% |
| Sands Capital Management LLCas of 31 Mar 2018 | 2.71m | 3.38% |
| Polen Capital Management LLCas of 31 Mar 2018 | 2.67m | 3.33% |
| T. Rowe Price Associates, Inc.as of 31 Mar 2018 | 1.35m | 1.68% |
| Henderson Global Investors Ltd.as of 31 Mar 2018 | 1.13m | 1.41% |
| Wellington Management Co. LLPas of 31 Mar 2018 | 975.15k | 1.22% |
| Northern Trust Investments, Inc.as of 31 Mar 2018 | 971.17k | 1.21% |
